Neogen (NEOG) Depreciation & Amortization (CF) (2010 - 2025)

Neogen's (NEOG) quarterly Depreciation & Amortization (CF) came in at $3.3 million in Q4 2025, down 88.86% year-on-year from $30.0 million in Q4 2024, and down 88.48% quarter-over-quarter from $29.1 million in Q3 2025.

Neogen (NEOG) Depreciation & Amortization (CF) (2010 - 2025) Analysis & Trends

Neogen's Depreciation & Amortization (CF) history runs 16 years deep, the most recent figure standing at $3.3 million for Q4 2025.

  • On a quarterly basis, Depreciation & Amortization (CF) fell 88.86% year-over-year to $3.3 million in Q4 2025; TTM through Feb 2026 was $62.7 million, a 46.93% decrease from a year earlier, with the FY2025 full-year figure at $119.5 million, up 2.37% from the prior year.
  • Depreciation & Amortization (CF) retreated to $3.3 million in Q4 2025 per NEOG's latest filing, from $29.1 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $30.3 million in Q2 2025 and bottomed at $3.3 million in Q4 2025.
  • The 5-year median for Depreciation & Amortization (CF) is $28.0 million (2023), against an average of $19.6 million.
  • Across the five-year window, Depreciation & Amortization (CF) surged 401.55% in 2023 and plunged 88.86% in 2025, its largest moves.
  • Year by year, Depreciation & Amortization (CF) stood at $5.8 million in 2021, then jumped by 358.71% to $26.7 million in 2022, then gained by 10.21% to $29.5 million in 2023, then rose by 1.96% to $30.0 million in 2024, then plunged by 88.86% to $3.3 million in 2025.
  • Per Business Quant, the three latest NEOG Depreciation & Amortization (CF) figures stand at $3.3 million (Q4 2025), $29.1 million (Q3 2025), and $30.3 million (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 381.00 Mn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 120.00 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 716.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 351.00 Mn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 40.90 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 67.10 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 310.25 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 78.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Neogen 2.09 Bn 1.93 Bn 99.00 Mn -

Historic Data

Download Data
DateValue
Nov 30, 2025 3.35 Mn
Nov 30, 2025 3.35 Mn
Aug 31, 2025 29.06 Mn
Aug 31, 2025 29.06 Mn
May 31, 2025 30.28 Mn
May 31, 2025 30.28 Mn
Feb 28, 2025 29.40 Mn
Feb 28, 2025 29.40 Mn
Nov 30, 2024 30.05 Mn
Nov 30, 2024 30.05 Mn
Aug 31, 2024 29.80 Mn
Aug 31, 2024 29.80 Mn
May 31, 2024 28.86 Mn
May 31, 2024 28.86 Mn
Feb 29, 2024 29.65 Mn
Feb 29, 2024 29.65 Mn
Nov 30, 2023 29.47 Mn
Nov 30, 2023 29.47 Mn
Aug 31, 2023 28.73 Mn
Aug 31, 2023 28.73 Mn